Maha Radhakrishnan
Board Member
Candel Therapeutics, Inc. (CADL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Maha Radhakrishnan
Maha Radhakrishnan is recorded as Board Member at Candel Therapeutics, Inc. (CADL). Maha Radhakrishnan was last confirmed as Board Member at Alto Neuroscience, Inc. (ANRO) in a filing dated April 1, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-01-01–present
-
Start not stated–2025-04-01
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Candel Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Paul Peter Tak CEO, Board Member
- Charles Schoch CFO
- Jason Amello CFO
- Diem Nguyen, Ph.D. Board Member
- Edward J. Benz Board Member
- Gary Nabel Board Member
- Joseph Papa Board Member
- Maha Radhakrishnan, M.D. Board Member
- Martine Zimmermann Board Member
- Nicoletta Loggia, Ph.D., R.Ph. Board Member
Recent activity
No call appearances or filed executive changes recorded yet.